Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Interventional × Immunotherapy × Clear all

Phase

Status

Not yet recruiting 3 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4181 Neoplasms 3493 Prostatic Neoplasms 2031 Carcinoma, Non-Small-Cell Lung 1860 Colorectal Neoplasms 1719 Lung Neoplasms 1420 Multiple Myeloma 1216 Lymphoma 1185 Neoplasm Metastasis 1164 Leukemia, Myeloid, Acute 1148 Melanoma 1065 Pancreatic Neoplasms 1012 Leukemia 1004 Ovarian Neoplasms 1000 Lymphoma, Non-Hodgkin 933 Precursor Cell Lymphoblastic Leukemia-Lymphoma 891 Head and Neck Neoplasms 874 Leukemia, Lymphocytic, Chronic, B-Cell 812 Brain Neoplasms 763 Colonic Neoplasms 748 Lymphoma, Follicular 739 Stomach Neoplasms 714 Glioblastoma 711 Carcinoma, Hepatocellular 710 Recurrence 707 Rectal Neoplasms 643 Lymphoma, Large B-Cell, Diffuse 633 Uterine Cervical Neoplasms 611 Carcinoma, Renal Cell 591 Myelodysplastic Syndromes 581

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04225390 2026-02-10

PROMIT

University of Erlangen-Nürnberg Medical School

Phase 2 Completed

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡